Bumper Offer - Urjas oil Just @ Rs. 1
Dactive 6.25 Tablet SR is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult(Male) |
|
| Adult(Female) |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Dactive 6.25 Tablet SR is used -
Moderate
Mild
Is the use of Dactive 6.25 Tablet SR safe for pregnant women?
Dactive can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Dactive right away. Take your doctor's advice before taking it again.
Is the use of Dactive 6.25 Tablet SR safe during breastfeeding?
Dactive can cause moderate side effects on breastfeeding women. If you feel its side effects, then stop taking this drug and consult your doctor. Take this medicine again only if your doctor advises to do so.
What is the effect of Dactive 6.25 Tablet SR on the Kidneys?
Dactive is not harmful for kidneys.
What is the effect of Dactive 6.25 Tablet SR on the Liver?
Dactive has very mild side effects on the liver.
What is the effect of Dactive 6.25 Tablet SR on the Heart?
There are no any side effects of Dactive for the heart.
Dactive 6.25 Tablet SR should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Dactive 6.25 Tablet SR unless your doctor advises you to do so -
Is this Dactive 6.25 Tablet SR habit forming or addictive?
Dactive 6.25 Tablet SR can be addictive. You should not take it without medical advice.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Dactive 6.25 Tablet SR. So it is best to avoid driving.
Is it safe?
Yes, but take Dactive 6.25 Tablet SR only as per medical advice.
Is it able to treat mental disorders?
Yes, in many cases, taking Dactive 6.25 Tablet SR can help with mental disorders.
Interaction between Food and Dactive 6.25 Tablet SR
It is safe to take Dactive 6.25 Tablet SR with food.
Interaction between Alcohol and Dactive 6.25 Tablet SR
Consumption of alcohol and Dactive 6.25 Tablet SR together may have severe effects on your health.
Yes, Dactive might cause anxiety in some cases. It is a rare side effect of this drug. This effect is reversible in nature and the anxiety is relieved after discontinuation of this drug. If you are experiencing anxiety more frequently after taking this drug then discuss this with your doctor.
Dactive contains zolpidem which is a sedative & hypnotic agent. It is presumed that zolpidem works by producing the calming effect on the brain by decreasing the excessive neuronal activity of the brain which induces sleep.
Yes, Dactive can be taken with fluoxetine. No clinically significant drug interaction has been reported between them. However, if you feel any discomfort after taking this drug along with fluoxetine then do not hesitate to inform your doctor.
No, Dactive is not a benzodiazepine. It is a nonbenzodiazepine drug that belongs to the class of drug known as imidazopyridine which produces sedative effects similar to the benzodiazepines.
No, Dactive does not cause weight changes (weight gain or loss). It has not been reported by the patients who are taking this drug. However, if you are experiencing any unusual weight changes then it might be due to some medical condition and you are advised to discuss it with your doctor.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ambien® (zolpidem tartrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 406-407
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1296-1298
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ambien® (zolpidem tartrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 406-407
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1296-1298
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ambien® (zolpidem tartrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 406-407
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1296-1298
